GGrantIndex
← Leaderboards

Meggan Mackay

Feinstein Institute For Medical Research

Google Scholar ↗PubMed ↗ORCID ↗
$9,983,431
Attributed
$9,983,431
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2008–25
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,983,431 · 10

By mechanism

P01$9,194,244 · 4
U34$768,190 · 1
M01$20,997 · 5

Top collaborators

No co-investigators on record.

Most similar at Feinstein Institute For Medical Research

Same institution · by research overlap

Others in their field

Top investigators on “Brain”

Research focus

BrainMouse ModelSystemic Lupus ErythematosusSerumLupusPositron-Emission TomographyImpaired CognitionMetabolismCognitionMetabolicRestImageMagnetic Resonance ImagingCognitiveGrantMeasurementN-Methyl-D-Aspartate ReceptorsFluorodeoxyglucose Positron Emission TomographyContrast EnhancedReportingImaging BiomarkerAntibodiesFunctional Magnetic Resonance ImagingFc Receptor

Grant awards (23)

Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE$845,097
P01 · FY2025 · AI · contact PI
Assessing Brain Dysfunction in Individuals with SLE: Heterogeneity, Mechanisms and Metrics$572,669
P01 · FY2025 · AI · contact PI
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE$132,967
P01 · FY2025 · AI · contact PI
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE$90,908
P01 · FY2025 · AI · contact PI
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE$1,003,698
P01 · FY2024 · AI · contact PI
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance$630,309
P01 · FY2024 · AI · contact PI
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance$796,076
P01 · FY2023 · AI · contact PI
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance$917,304
P01 · FY2022 · AI · contact PI
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance$843,150
P01 · FY2021 · AI · contact PI
Project 2- Correlating microglial activation with blood brain barrier integrity and neurocognitive performance$662,506
P01 · FY2020 · AI · contact PI
Imaging antibody effects in SLE patients$617,901
P01 · FY2018 · AI · contact PI
Imaging antibody effects in SLE patients$568,313
P01 · FY2017 · AI · contact PI
Imaging antibody effects in SLE patients$366,963
P01 · FY2016 · AI · contact PI
Imaging antibody effects in SLE patients$571,038
P01 · FY2015 · AI · contact PI
Imaging antibody effects in SLE patients$575,345
P01 · FY2014 · AI · contact PI
Treatment of SLE with Ajulemic Acid, a Non-Psychoactive Cannabinoid Derivative$358,063
U34 · FY2014 · AR · contact PI
Treatment of SLE with ajulemic acid, a non-psychoactive cannabinoid derivative$90,557
U34 · FY2014 · AR · contact PI
Treatment of SLE with ajulemic acid, a non-psychoactive cannabinoid derivative$319,570
U34 · FY2013 · AR · contact PI
FUNCTIONAL MRI OF COGNITIVE AND EMOTIONAL ABNORMALITIES IN PATIENTS WITH LUPUS$9,326
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PHASE II TRIAL OF CTLA4IG$8,479
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: PHASE II TRIAL OF CTLA4IG IN THE TREATMENT OF LUPUS NEPHRITIS$1,844
M01 · FY2009 · RR · contact PI
FUNCTIONAL MRI OF COGNITIVE AND EMOTIONAL ABNORMALITIES IN PATIENTS WITH LUPUS$428
M01 · FY2009 · RR · contact PI
FUNCTIONAL MRI OF COGNITIVE AND EMOTIONAL ABNORMALITIES IN PATIENTS WITH SYSTEMI$920
M01 · FY2008 · RR · contact PI